论文部分内容阅读
作者测定血清Ⅲ型前胶原肽(pcⅢ-p)值,了解其在各种肝脏病特别是肝癌时出现的意义,并就其临床实用性进行了探讨。对象和方法选择内科住院之肝脏病人213例,健康人23例,共236例。肝病细分:原发性肝癌63例,转移性肝癌23例,肝硬化50例,慢性肝炎45例(非活动型9例,活动型28,例未做活检8例),不合并肝硬化的酒精性肝损害21例,急性肝炎11例。pcⅢp 值的测定是依Rhode 等方法用Roeckst 社制的RIA 药盒。结果在原发性肝癌、转移性肝癌和酒精性肝炎合并肝硬化的病例中出现显著高值,把非癌慢性肝损害的pc
The authors measured the serum level of type Ⅲ procollagen peptide (pcⅢ-p) value, to understand its significance in a variety of liver diseases, especially liver cancer, and its clinical practice was discussed. Subjects and methods: 213 liver patients and 236 healthy subjects were selected as medical inpatients. Subdivision of liver disease: 63 cases of primary liver cancer, 23 cases of metastatic liver cancer, cirrhosis of the liver in 50 cases, 45 cases of chronic hepatitis (inactive 9 cases, 28 cases of active biopsy in 8 cases), without cirrhosis Alcoholic liver damage in 21 cases, 11 cases of acute hepatitis. The pcIIIp value was determined using the RIA kit manufactured by Roeckst, Inc., by Rhode et al. Results in patients with primary liver cancer, metastatic liver cancer and alcoholic hepatitis with cirrhosis in patients with significant high value, the non-cancerous chronic liver damage pc